tezepelumab

tezepelumab Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA THOUSAND OAKS, Calif., May 10, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for tezepelumab, a potential first-in-class medicine in severe asthma. The submission is supported by positive clinical trial results from the PATHFINDER clinical program including the pivotal NAVIGATOR Phase […]

Continue reading »

Sugar-sweetened drinks linked to increased risk of colorectal cancer in women under 50

Colorectal cancer diagnoses have increased among people under age 50 in recent years, and researchers are seeking reasons why. A new study led by Washington University School of Medicine in St. Louis has found a link between drinking sugar-sweetened beverages and an increased risk of developing colorectal cancer in women under age 50. The findings suggest that heavy consumption of […]

Continue reading »

Prince Harry Speaks To Australian Farmers On Mental health

Communal Spirit Prince Harry recently delivered a powerful message to farmers in Australia in which he addressed the issue of mental health. Preceding the commencement of Invictus Games, Prince Harry and Meghan, his wife, paid a visit to a part of Dunno where the locals had been having issues with unfavorable climatic conditions. Prince Harry, while delivering his speech encouraged the people to be on the lookout for their fellow community members. Prince Harry acknowledged […]

Continue reading »

mobocertinib

mobocertinib Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE) April 27, 2021– Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New […]

Continue reading »

Neglected Tropical Diseases (NTDs) and Vaccines

Current estimates indicate that over 1 billion of the world’s poorest people are affected by neglected tropical diseases (NTDs). NTDs are typically found in areas of extreme poverty within Africa, Asia, and Latin America. Image Credit: bsd/Shutterstock.com Introduction By definition, a neglected tropical disease is a disease that causes significant illness for people around the world. There is a direct […]

Continue reading »

What is a Live-Attenuated Vaccine?

Live-attenuated vaccines are very effective vaccines used in the prevention of a variety of diseases including influenza, chickenpox, measles, polio and TB. Image Credit: LookerStudio/Shutterstock.com What are live-attenuated vaccines? Live-attenuated vaccines differ from traditional inactivated vaccines where the pathogen is “killed”, and as the name suggests the pathogen (typically a virus) remains active in live vaccines, however, is attenuated or […]

Continue reading »

Odibo named director of maternal-fetal & ultrasound division in OB-GYN

Anthony Odibo, MD, an internationally respected maternal-fetal medicine expert, has been named director of the Division of Maternal-Fetal Medicine & Ultrasound in the Department of Obstetrics & Gynecology at Washington University School of Medicine in St. Louis. He also has been appointed vice chair of obstetrics in the department. Odibo previously served as a division director and vice chair in […]

Continue reading »

abrocitinib

abrocitinib Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis NEW YORK–(BUSINESS WIRE) April 07, 2021 — Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority review period for the New Drug Application (NDA) for abrocitinib for the treatment of […]

Continue reading »
1 2 3 4 141